LAM
GILD icon

L2 Asset Management’s Gilead Sciences GILD Stock Holding History

L2 Asset Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.15M Sell
64,505
-1,656
-3% -$218K 0.85% 35
2026
Q1 		$9.22M Sell
66,161
-4,759
-7% -$666K 0.88% 31
2025
Q4 		$8.7M Buy
70,920
+10,200
+17% +$1.24M 1.16% 18
2025
Q3 		$6.74M Buy
60,720
+4,204
+7% +$478K 0.98% 29
2025
Q2 		$6.27M Buy
56,516
+28,592
+102% +$3.04M 1.03% 24
2025
Q1 		$3.13M Buy
27,924
+23,117
+481% +$2.39M 0.64% 53
2024
Q4 		$444K Sell
4,807
-118
-2% -$10.6K 0.1% 143
2024
Q3 		$413K Sell
4,925
-6,171
-56% -$471K 0.11% 132
2024
Q2 		$761K Sell
11,096
-9,500
-46% -$634K 0.23% 84
2024
Q1 		$1.51M Buy
20,596
+5,852
+40% +$450K 0.5% 55
2023
Q4 		$1.19M Buy
14,744
+10,512
+248% +$818K 0.49% 56
2023
Q3 		$1.73M Sell
4,232
-54,287
-93% -$4.18M 0.81% 39
2023
Q2 		$4.56M Sell
58,519
-166
-0.3% -$13.2K 2.23% 5
2023
Q1 		$4.87M Buy
58,685
+3,238
+6% +$268K 2.68% 6
2022
Q4 		$4.76M Buy
55,447
+344
+0.6% +$27.2K 2.96% 6
2022
Q3 		$3.4M Buy
55,103
+5,115
+10% +$323K 2.34% 9
2022
Q2 		$3.09M Buy
49,988
+15,970
+47% +$989K 2.24% 8
2022
Q1 		$2.02M Buy
34,018
+14,649
+76% +$936K 1.16% 28
2021
Q4 		$1.41M Buy
19,369
+16,216
+514% +$1.12M 0.98% 37
2021
Q3 		$220K Sell
3,153
-6,296
-67% -$442K 0.56% 55
2021
Q2 		$651K Sell
9,449
-8,964
-49% -$599K 0.6% 57
2021
Q1 		$1.19M Sell
18,413
-2,435
-12% -$157K 1.23% 35
2020
Q4 		$1.22M Sell
20,848
-6,293
-23% -$380K 0.83% 37
2020
Q3 		$1.72M Buy
27,141
+772
+3% +$53.5K 1.38% 28
2020
Q2 		$2.03M Sell
26,369
-8,362
-24% -$641K 1.84% 22
2020
Q1 		$2.6M Buy
34,731
+13,910
+67% +$961K 2.91% 11
2019
Q4 		$1.35M Buy
+20,821
New +$1.36M 1.19% 38

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

L2 Asset Management's GILD Position: Q2 2026 in Review

L2 Asset Management reduced its Gilead Sciences (GILD) stake by 2.5% in Q2 2026, selling an estimated $218K and leaving 64,505 shares worth $8.15M. The position accounts for 0.85% of the portfolio, ranked #35.

L2 Asset Management first reported a position in GILD in Q4 2019 and has held it in 27 quarters since. The position peaked at $9.22M in Q1 2026. 2,279 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • L2 Asset Management held 64,505 shares of Gilead Sciences worth $8.15M as of Q2 2026.
  • L2 Asset Management sold 1,656 Gilead Sciences shares in Q2 2026, an estimated $218K.
  • Gilead Sciences made up 0.85% of L2 Asset Management's portfolio in Q2 2026, its #35 holding.
  • L2 Asset Management first reported a position in Gilead Sciences in Q4 2019 and has held it in 27 quarters since.
  • L2 Asset Management's Gilead Sciences position peaked at $9.22M in Q1 2026.
  • 2,279 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on L2 Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.